We are live on ! Find out more
ECM

EagleClaw Capital Management Portfolio holdings

AUM $714M
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+24.24%
3 Year Est. Return
+96.54%
5 Year Est. Return
+138.84%
10 Year Est. Return
+573.51%
AUM
$273M
AUM Growth
+$28M
Cap. Flow
+$6.95M
Cap. Flow %
2.54%
Top 10 Hldgs %
34.26%
Holding
135
New
7
Increased
39
Reduced
49
Closed
5

Top Buys

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$1.27M
2
BMY icon
Bristol-Myers Squibb
BMY
+$809K
3
QCOM icon
Qualcomm
QCOM
+$730K
4
TPL icon
Texas Pacific Land
TPL
+$705K
5
DIS icon
Walt Disney
DIS
+$657K

Top Sells

Rank Stock Value
1
COF icon
Capital One
COF
+$684K
2
CELG
Celgene Corp
CELG
+$655K
3
AAPL icon
Apple
AAPL
+$604K
4
APA icon
APA Corp
APA
+$302K
5
CTWS
Connecticut Water Service Inc
CTWS
+$231K

Sector Composition

Rank Sector Weight
1 Technology 15.51%
2 Financials 15.48%
3 Consumer Discretionary 15.08%
4 Industrials 14.38%
5 Healthcare 13.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
26
NVIDIA
NVDA
$4.86T
$3.18M 1.16%
538,800
-1,000
-0.2% -$5.2K
BMY icon
27
Bristol-Myers Squibb
BMY
$133B
$3.07M 1.12%
47,807
+14,125
+42% +$809K
PANW icon
28
Palo Alto Networks
PANW
$270B
$3.03M 1.11%
78,450
-150
-0.2% -$5.67K
ICE icon
29
Intercontinental Exchange
ICE
$85.6B
$3.02M 1.1%
32,475
+13,725
+73% +$1.27M
QCOM icon
30
Qualcomm
QCOM
$155B
$3M 1.1%
34,040
+8,725
+34% +$730K
CVX icon
31
Chevron
CVX
$392B
$2.95M 1.08%
24,572
+2,925
+14% +$345K
GILD icon
32
Gilead Sciences
GILD
$162B
$2.84M 1.04%
43,752
+3,925
+10% +$256K
JNJ icon
33
Johnson & Johnson
JNJ
$618B
$2.82M 1.03%
19,324
+2,450
+15% +$332K
MSGS icon
34
Madison Square Garden
MSGS
$9.48B
$2.8M 1.03%
13,375
-491
-4% -$96.3K
IBM icon
35
IBM
IBM
$211B
$2.76M 1.01%
21,594
+1,177
+6% +$153K
CI icon
36
Cigna
CI
$73.7B
$2.57M 0.94%
12,587
+452
+4% +$82.9K
FDX icon
37
FedEx
FDX
$72.7B
$2.56M 0.94%
16,960
+2,575
+18% +$397K
FMC icon
38
FMC
FMC
$1.34B
$2.53M 0.93%
25,395
– –
TMO icon
39
Thermo Fisher Scientific
TMO
$213B
$2.53M 0.93%
7,800
– –
HON icon
40
Honeywell
HON
$77B
$2.52M 0.92%
15,086
+689
+5% +$113K
NVO
41
Novo Nordisk
NVO
$208B
$2.4M 0.88%
82,898
+2,000
+2% +$55.4K
CVS icon
42
CVS Health
CVS
$133B
$2.28M 0.83%
30,791
-390
-1% -$27.4K
CL icon
43
Colgate-Palmolive
CL
$73.1B
$2.12M 0.77%
30,702
– –
NVS icon
44
Novartis
NVS
$297B
$2.09M 0.77%
22,115
– –
GOOGL icon
45
Alphabet (Google) Class A
GOOGL
$4.36T
$2.07M 0.76%
31,000
-120
-0.4% -$7.74K
WRK
46
DELISTED
WestRock Company
WRK
$1.96M 0.72%
45,775
-1,825
-4% -$71.2K
HOLX
47
DELISTED
Hologic
HOLX
$1.91M 0.7%
36,650
– –
LMT icon
48
Lockheed Martin
LMT
$134B
$1.9M 0.69%
4,861
+225
+5% +$86.3K
WM icon
49
Waste Management
WM
$90.6B
$1.85M 0.68%
16,201
– –
EMR icon
50
Emerson Electric
EMR
$83.9B
$1.84M 0.67%
24,213
+350
+1% +$25.2K
1
2
3 4 5

Similar funds

GEA
Glen Eagle Advisors Kingston, New Jersey $714M AUM 18.87% 1-Year Est. Return
ACGDR
Atmos Capital Gestao de Recursos Leblon - Rio De Janeiro, Brazil $714M AUM 35.97% 1-Year Est. Return
CFGSD
Compass Financial Group (South Dakota) Sioux Falls, South Dakota $715M AUM 15.96% 1-Year Est. Return
LFA
Legacy Financial Advisors Covington, Kentucky $715M AUM 22.34% 1-Year Est. Return
IWP
Insight Wealth Partners Plano, Texas $713M AUM 16.55% 1-Year Est. Return
DCM
Dimension Capital Management Coral Gables, Florida $713M AUM 18.57% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return

EagleClaw Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, EagleClaw Capital Management held 135 positions worth $273M, up 11% from $245M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

EagleClaw Capital Management's Q4 2019 filing shows 7 new, 39 increased, 49 reduced and 5 closed positions. Its largest new stake was Moody's: 2,500 shares worth $594K. The largest sale was Capital One, an estimated $684K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Consumer Discretionary.

  • EagleClaw Capital Management's largest Q4 2019 buy was Moody's: 2,500 shares worth $594K.
  • EagleClaw Capital Management added most to Intercontinental Exchange in Q4 2019, an estimated $1.27M increase.
  • EagleClaw Capital Management's biggest Q4 2019 reduction was Capital One, cutting an estimated $684K.
  • EagleClaw Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $655K.
  • EagleClaw Capital Management's ten largest holdings make up 34% of its $273M portfolio in Q4 2019.
  • EagleClaw Capital Management opened 7 new positions and closed 5 in Q4 2019.
  • EagleClaw Capital Management's portfolio value rose 11% quarter-over-quarter to $273M.

Based on EagleClaw Capital Management's 13F filing for Q4 2019, filed 27 Jan 2020.